Product
TQB2103
1 clinical trial
1 indication
Indication
Advanced Malignant NeoplasmClinical trial
A Phase I Clinical Trial Evaluating Tolerance, Safety, Pharmacokinetics, and Initial Effectiveness of TQB2103 for Injection in Patients With Advanced Cancers.Status: Recruiting, Estimated PCD: 2025-05-01